StockData
Precigen, Inc. logo

Precigen, Inc. (PGEN) stock

PGENNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 2/30
$4.21+0.05 (+1.20%)

Close on Nov 20, 2026Market cap $1.51BP/E –Yield –

Precigen net income

Net income is the profit left for shareholders after every expense, interest and tax.

Precigen's net income for the twelve months ending Jun 30, 2026 was -$157.71M. For fiscal 2025 it was -$250.64M. The highest annual figure on record is $28.32M in fiscal 2022.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$250.64M–
FY2024Dec 31, 2024-$126.24M–
FY2023Dec 31, 2023-$95.90M-438.7%
FY2022Dec 31, 2022$28.32M–
FY2021Dec 31, 2021-$92.17M–
FY2020Dec 31, 2020-$170.52M–
FY2019Dec 31, 2019-$322.32M–
FY2018Dec 31, 2018-$509.34M–
FY2017Dec 31, 2017-$117.02M–
FY2016Dec 31, 2016-$186.61M–
FY2015Dec 31, 2015-$84.49M–
FY2014Dec 31, 2014-$81.82M–
FY2013Dec 31, 2013-$38.98M–
FY2012Dec 31, 2012-$81.87M–
FY2011Dec 31, 2011-$85.28M–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$20.07M–
Q1 FY2026Mar 31, 2026-$7.93M–
Q4 FY2025Dec 31, 2025-$23.50M–
Q3 FY2025Sep 30, 2025-$146.34M–
Q2 FY2025Jun 30, 2025-$26.64M–
Q1 FY2025Mar 31, 2025-$54.15M–
Q4 FY2024Dec 31, 2024-$19.73M–
Q3 FY2024Sep 30, 2024-$23.98M–
Q2 FY2024Jun 30, 2024-$58.79M–
Q1 FY2024Mar 31, 2024-$23.74M–
Q4 FY2023Dec 31, 2023-$33.06M–
Q3 FY2023Sep 30, 2023-$19.80M-122.7%
Q2 FY2023Jun 30, 2023-$20.32M–
Q1 FY2023Mar 31, 2023-$22.73M–
Q4 FY2022Dec 31, 2022-$22.18M–
Q3 FY2022Sep 30, 2022$87.38M–
Q2 FY2022Jun 30, 2022-$17.64M–
Q1 FY2022Mar 31, 2022-$19.25M–
Q4 FY2021Dec 31, 2021-$25.03M–
Q3 FY2021Sep 30, 2021-$29.76M–
Q2 FY2021Jun 30, 2021-$20.05M–
Q1 FY2021Mar 31, 2021-$17.32M–
Q4 FY2020Dec 31, 2020-$41.66M–
Q3 FY2020Sep 30, 2020-$29.51M–
Q2 FY2020Jun 30, 2020-$43.35M–
Q1 FY2020Mar 31, 2020-$56.00M–
Q4 FY2019Dec 31, 2019-$169.22M–
Q3 FY2019Sep 30, 2019-$53.63M–
Q2 FY2019Jun 30, 2019-$38.77M–
Q1 FY2019Mar 31, 2019-$60.71M–
Q4 FY2018Dec 31, 2018-$340.47M–
Q3 FY2018Sep 30, 2018-$57.32M–
Q2 FY2018Jun 30, 2018-$65.38M–
Q1 FY2018Mar 31, 2018-$46.17M–
Q4 FY2017Dec 31, 2017-$27.27M–
Q3 FY2017Sep 30, 2017-$39.69M–
Q2 FY2017Jun 30, 2017-$18.66M–
Q1 FY2017Mar 31, 2017-$31.40M–
Q4 FY2016Dec 31, 2016-$44.14M–
Q3 FY2016Sep 30, 2016-$28.98M–

More Precigen figures

See a number that looks wrong?